Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nobuyuki Okamura

Showing results (31-40 of 208) with videos related to

Pageof 21
Sort By:
Current Alzheimer Research|June 24, 2016
18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical FeaturesShozo Furumoto, Tetsuro Tago, Ryuichi Harada, et al.
International Review of Neurobiology|July 18, 2009
Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout miceNaoko Takino, Eiko Sakurai, Atsuo Kuramasu, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[In vivo amyloid imaging using BF-227]Nobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, et al.
Radiological Physics and Technology|October 18, 2018
Investigation of the quantitative accuracy of low-dose amyloid and tau PET imagingYing-Hwey Nai, Shoichi Watanuki, Manabu Tashiro, et al.
Frontiers in Neurology|July 12, 2019
Assessment of Amyloid Deposition in Patients With Probable REM Sleep Behavior Disorder as a Prodromal Symptom of Dementia With Lewy Bodies Using PiB-PETRyota Kobayashi, Hiroshi Hayashi, Shinobu Kawakatsu, et al.
Current Neurology and Neuroscience Reports|September 21, 2014
Tau PET imaging in Alzheimer's diseaseNobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, et al.
International Journal of Molecular Sciences|May 28, 2022
MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer's Disease Model MiceShinWoo Kang, Jinho Kim, Sang-Yoon Lee, et al.
Clinical and Translational Imaging|August 28, 2018
The development and validation of tau PET tracers: current status and future directionsNobuyuki Okamura, Ryuichi Harada, Aiko Ishiki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2016
[The trend of developing new disease-modifying drugs in Alzheimer's disease]Hiroyuki Arai, Katsutoshi Furukawa, Naoki Tomita, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 3, 2017
Development of molecular imaging probe targeted at Alzheimer's disease pathologyNobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, et al.
Pageof 21

Showing results (31-40 of 208) with videos related to

Sort By:
Pageof 21
Current Alzheimer Research|June 24, 2016
18F-Labeled 2-Arylquinoline Derivatives for Tau Imaging: Chemical, Radiochemical, Biological and Clinical FeaturesShozo Furumoto, Tetsuro Tago, Ryuichi Harada, et al.
International Review of Neurobiology|July 18, 2009
Roles of the histaminergic neurotransmission on methamphetamine-induced locomotor sensitization and reward: a study of receptors gene knockout miceNaoko Takino, Eiko Sakurai, Atsuo Kuramasu, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 14, 2012
[In vivo amyloid imaging using BF-227]Nobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, et al.
Radiological Physics and Technology|October 18, 2018
Investigation of the quantitative accuracy of low-dose amyloid and tau PET imagingYing-Hwey Nai, Shoichi Watanuki, Manabu Tashiro, et al.
Frontiers in Neurology|July 12, 2019
Assessment of Amyloid Deposition in Patients With Probable REM Sleep Behavior Disorder as a Prodromal Symptom of Dementia With Lewy Bodies Using PiB-PETRyota Kobayashi, Hiroshi Hayashi, Shinobu Kawakatsu, et al.
Current Neurology and Neuroscience Reports|September 21, 2014
Tau PET imaging in Alzheimer's diseaseNobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, et al.
International Journal of Molecular Sciences|May 28, 2022
MicroPET Imaging Assessment of Brain Tau and Amyloid Deposition in 6 × Tg Alzheimer's Disease Model MiceShinWoo Kang, Jinho Kim, Sang-Yoon Lee, et al.
Clinical and Translational Imaging|August 28, 2018
The development and validation of tau PET tracers: current status and future directionsNobuyuki Okamura, Ryuichi Harada, Aiko Ishiki, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2016
[The trend of developing new disease-modifying drugs in Alzheimer's disease]Hiroyuki Arai, Katsutoshi Furukawa, Naoki Tomita, et al.
Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica|October 3, 2017
Development of molecular imaging probe targeted at Alzheimer's disease pathologyNobuyuki Okamura, Ryuichi Harada, Shozo Furumoto, et al.
Pageof 21